Scott B. Ullem - 16 Feb 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Chief Financial Officer
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 16 Feb 2024
Transactions value $: -$14,971
Form type: 4
Filing time: 16 Feb 2024, 18:40:49 UTC
Previous filing: 01 Feb 2024
Next filing: 29 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	-$14,970	-174	-0.9%	$86.04	19,074	16 Feb 2024	Direct
holding	EW	Common Stock						266,318	16 Feb 2024	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.